Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | REN | P00797 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL25383492 | 1.00 | CTSL (0.53) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| SCHEMBL9437417 | 0.93 | CTSL (0.53) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| SCHEMBL20583780 | 0.93 | CTSL (0.53) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL7779525 | 0.92 | CTSL (0.52) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL11290000 | 0.92 | CTSL (0.52) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL966704 | 0.90 | CTSL (0.51) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL31360487 | 0.85 | CTSL (0.45) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| Trifluoroacetic Acid SCHEMBL31360749 | 0.85 | CTSL (0.45) | CTSLPTPN1MEN1ALDH1A1HPGD | |
| SCHEMBL8851538 | 0.85 | ALDH1A1 (0.53) | CTSLMEN1ALDH1A1HPGDKMT2A | |
| SCHEMBL8851532 | 0.85 | ALDH1A1 (0.53) | CTSLMEN1ALDH1A1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | UNIVERSITEIT GENT (BE) | 2025-05-29 | — | — | US | claimed |
| EP-4482849-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2025-01-01 | — | — | EP | claimed |
| WO-2023161962-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-08-31 | — | — | WO | claimed |
| EP-3389643-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2023-05-03 | — | — | EP | claimed |
| CN-108884132-B | Muramyl peptide derivatives a compound their synthesis and their use | 巴拉特生物技术国际有限公司 | 2022-10-04 | — | — | CN | claimed |
| EP-3387005-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2022-08-24 | — | — | EP | claimed |
| CN-108883080-B | Muramyl peptide derivative compounds, their synthesis and use thereof | 巴拉特生物技术国际有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-10576147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2020-03-03 | — | — | US | claimed |
| US-20180371023-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2018-12-27 | — | — | US | claimed |
| US-20180360957-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2018-12-20 | — | — | US | claimed |
| EP-3389643-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | Bharat Biotech International Limited (IN) | 2018-10-24 | — | — | EP | claimed |
| EP-3387005-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | Bharat Biotech International Limited (IN) | 2018-10-17 | — | — | EP | claimed |
| WO-2017103944-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2017-06-22 | — | — | WO | claimed |
| WO-2017098529-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2017-06-15 | — | — | WO | claimed |
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | UNIVERSITEIT GENT (BE) | 2025-05-29 | — | — | US | disclosed |
| WO-2025027624-A1 | CYCLIC GLYCOLIPOPEPTIDE VACCINE ADJUVANTS AND THE PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2025-02-06 | — | — | WO | disclosed |
| EP-4482849-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2025-01-01 | — | — | EP | disclosed |
| EP-0015468-B1 | 6-DEOXYGLUCOSAMINE-PEPTIDE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1982-12-29 | — | — | EP | disclosed |
| US-4314998-A | 6-Deoxyglucosamine-peptide derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1982-02-09 | — | — | US | disclosed |
| EP-0015468-A1 | 6-Deoxyglucosamine-peptide derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1980-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180360957-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | NOD2, HM13, HLA-DRB1 | CTSL 1279/4885PTPN1 4054/4885MEN1 1033/4885 |
| US-10576147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | NOD2, HM13, QRFPR | CTSL 1317/4885PTPN1 4177/4885MEN1 854/4885 |
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | NOD2, NOD1, TLR9 | CTSL 1704/4885PTPN1 2195/4885MEN1 1601/4885 |
| US-20180371023-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | NOD2, MICA, TLR9 | CTSL 1056/4885PTPN1 3277/4885MEN1 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.